Medical Oncologist
CION Cancer Clinics
Who cannot have atezolizumab plus bevacizumab for liver cancer? | CION Cancer Clinics
Atezolizumab plus bevacizumab is usually the first drug treatment for primary liver cancer that cannot be removed. It is not safe for everyone. Untreated large varices, recent bleeding, active autoimmune illness, a liver transplant or a liver that is struggling can rule it out. This page explains each reason, how your team checks for it, and what is offered instead. At CION Cancer Clinics, a multidisciplinary tumour board weighs your liver function and your scans before recommending any treatment.
NG
Medically reviewed by Dr. Naresh GunduConsultant Medical Oncologist · MBBS, DNB (Internal Medicine), DM (Medical Oncology, AIIMS) · last reviewed October 2026, next review due October 2027
17+specialists on panel
15,000+patients treated
35+centres across Telangana & AP
4.8★ / 800+Google rating
On this page
The short answer
Who is not offered atezolizumab plus bevacizumab?
This combination is usually the first treatment offered for primary liver cancer (hepatocellular carcinoma, or HCC) that cannot be removed or treated locally. It is not offered to everyone. The main reasons are large varices that have not been treated, recent serious bleeding, an autoimmune illness that is active, a liver transplant, or a liver that is already struggling.
Each of these comes from one of the two drugs. Atezolizumab is an immunotherapy. It releases a brake on the immune system, so anything that makes the immune system dangerous to wake up is a reason for caution. Bevacizumab blocks the growth of new blood vessels, so anything that raises the risk of bleeding, clotting or poor wound healing is a reason for caution. You can read how the pair works on the main atezolizumab plus bevacizumab page.
Which liver cancer this page is about
This page is about cancer that started in the liver. If the cancer spread to the liver from the bowel, breast or elsewhere, the treatment follows the place it started, and this combination is not the usual choice. The systemic treatment options page explains the wider picture.
Being told this combination is not safe for you does not mean there is no treatment. It means a different drug is the safer start.What the team checks
What reasons might rule it out for me?
Most of these are checked before the first dose. Some are fixable, and some are not.
Varices or recent bleeding
Many people with cirrhosis have varices, which are swollen veins in the food pipe or stomach. Bevacizumab can make them more likely to bleed. Large varices that have not been treated, or a serious bleed in the recent past, usually mean waiting or choosing another drug.
This is often fixable with banding or tablets first.Active autoimmune illness
Conditions where the immune system already attacks the body, such as autoimmune hepatitis, lupus, active inflammatory bowel disease or some thyroid and nerve conditions, can flare when atezolizumab wakes the immune system up. Mild, settled conditions are judged case by case.
A liver transplant
After a transplant, immunotherapy can trigger the body to reject the new liver, and rejection can be life-threatening. Immunotherapy is generally avoided. Tablets are usually used instead.
A liver that is struggling
The research behind the combination was done mainly in people with well-kept liver function, called Child-Pugh A. With Child-Pugh B the evidence is thin, and with Child-Pugh C the liver usually cannot cope with any cancer drug.
Also weighed
- Blood pressure that is not controlled
- A lot of protein leaking into the urine
- A recent stroke, heart attack or blood clot
- Recent major surgery or a wound that has not healed
- Pregnancy
Not sure whether this applies to you?
Ask an oncologistBefore the first dose
How does the team decide whether it is safe for me?
Liver function and blood tests
Bilirubin, albumin and INR (a clotting test) tell the team how well the liver is working, and they set the Child-Pugh score. Kidney, thyroid and hepatitis B and C tests are done too. Active hepatitis B is controlled with antiviral tablets before or alongside treatment.
An endoscopy for varices
A thin camera passed down the food pipe looks for varices. CION arranges this through partner hospitals. If large varices are found, they are treated first. The reasons are on why the endoscopy comes first.
A full medical history
Your doctor will ask about bleeding, clots, strokes, heart problems, surgery, autoimmune conditions and every medicine you take, including blood thinners, painkillers and herbal tonics. Tell them everything, even what feels unrelated.
The tumour board decides
The scans, the blood results and the endoscopy report go to CION's multidisciplinary tumour board. Medical, surgical and radiation oncologists agree a plan together, and then explain it to you and your family.
If it is not for you
What is offered instead?
The reason
What is often considered
Large varices, not yet treated
Banding or beta-blocker tablets first, then the combination if the varices settle
High bleeding risk that cannot be fixed
Durvalumab plus tremelimumab, which uses no bevacizumab, or a tablet
Active autoimmune illness
Lenvatinib or sorafenib tablets, which do not stimulate the immune system
A previous liver transplant
Tablets, chosen with the transplant team
Child-Pugh C or very poor fitness
Supportive and symptom care, which is active treatment of how you feel
Leave a number, we will call you
One field. No form to fill in, and no charge for the call.
Commonly believed
What families often assume, and what is true
"If he cannot have the newest drug, nothing else will help."
The tablets lenvatinib and sorafenib were the standard for years and still control the cancer for many people. The sorafenib or lenvatinib page explains how one is chosen. Durvalumab plus tremelimumab is another option where it is available. Missing one combination closes one door, not all of them.
"We should not mention the old stomach bleed. It was years ago."
Tell the doctor. A past bleed changes how carefully the varices are checked. It does not automatically rule treatment out, but hiding it can make treatment dangerous.
"Varices mean he can never have bevacizumab."
Not always. Varices are often treated first with banding or tablets. Once they are controlled, the combination can usually be reconsidered.
"Her thyroid problem is minor, so it does not matter."
It still matters. A thyroid condition can change with immunotherapy. A stable thyroid problem rarely stops treatment. It means thyroid blood tests are checked regularly along the way.
Being straight with you
What this page cannot tell you
It cannot tell you whether you personally can have this combination. That depends on your endoscopy, your blood results, your scans and your history, read together by an oncologist who has examined you. Two people with the same stage of cancer can get different answers for good reasons.
It cannot weigh a borderline case
Many people sit in the middle: small varices, a mild autoimmune condition, or liver function between Child-Pugh A and B. In these cases the decision is a judgement, and evidence is thin. Ask your doctor what they are worried about and what would change their mind.
Who this page does not apply to
It does not apply to cancer that spread to the liver from another organ, to bile duct cancer, or to children with liver tumours. It also does not cover treatment that can remove or destroy a small tumour, such as surgery or ablation, which comes before drugs when it is possible.
If you are not sure why this combination was or was not offered, a second opinion from the tumour board can help you understand the reasoning.Questions we are asked
Common questions about who cannot have this combination
Can I have it if I have varices?
Often yes, once the varices are dealt with. Small varices may need only tablets. Large ones are usually banded first, over several visits arranged through a partner hospital. Treatment starts once your team is satisfied the bleeding risk has come down.
Can I have it with Child-Pugh B cirrhosis?
Sometimes, but the evidence is limited because the main trials mostly included people with Child-Pugh A. Your oncologist will weigh how well the liver is coping, how fit you are and what the cancer is doing. The Child-Pugh B page explains the options.
I have hepatitis B. Does that rule it out?
No. Hepatitis B is common in people with liver cancer in India. The virus needs to be controlled with antiviral tablets, prescribed by a hepatologist or physician, before or alongside treatment. Hepatitis B is controlled, not removed, so those tablets usually continue.
I take a blood thinner. Can I still have it?
It depends on why you take it. Blood thinners and bevacizumab together raise bleeding risk, so the team weighs the reason for the blood thinner against that risk. Never stop a blood thinner on your own. Ask your oncologist and the doctor who prescribed it to talk.
Can I have atezolizumab without bevacizumab?
The combination is what was tested and approved for liver cancer. Using immunotherapy alone is a different approach, used in selected situations. The immunotherapy alone page explains when doctors consider it and what is known.
Is older age a reason not to have it?
Age on its own is not a reason. What matters is fitness, liver function, other illnesses and bleeding risk. A fit older person may be a good candidate, and a younger person with poor liver function may not be. Ask how your overall health is being judged.
If I am refused now, can it be reconsidered later?
Yes, if the reason was fixable. Treated varices, a healed wound, controlled blood pressure or an improved liver can all reopen the option. A transplant or a serious active autoimmune illness usually does not change. Ask which kind of reason applies to you.
Where can I get my reports reviewed?
CION's tumour board reviews scans, blood results and endoscopy reports for second opinions. Bring every report and a list of all your medicines. Call the CION helpline and the team will tell you what to bring and arrange the consultation at a centre near you.
Your Specialists
Meet CION's liver cancer specialists. Bring your scan reports and liver blood tests.
Our medical and surgical oncologists plan liver cancer care together, weighing the tumour and how well your liver works before choosing surgery, a liver-directed procedure or medicines.
Medical Oncologist
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Medical Oncologist
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Medical Oncologist
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Medical Oncologist
Medical Oncologist
Surgical Oncologist
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Surgical Oncologist
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Sources
- American Cancer Society — Immunotherapy for Liver Cancer
- American Cancer Society — Targeted Drug Therapy for Liver Cancer
- EASL — EASL Clinical Practice Guidelines: management of hepatocellular carcinoma
- Cleveland Clinic — Esophageal Varices: Symptoms, Causes & Treatment
This page is general information, not a prescription. Do not change or stop any treatment based on what you read here. If anything is worrying you, contact your own treating team — or call our helpline and we will help you reach the right specialist.
Keep reading
Related pages
Atezolizumab plus bevacizumab for liver cancerHow the combination works and who it suitsWhy you need an endoscopy before bevacizumabThe check that most often delays or changes the planDurvalumab plus tremelimumab for liver cancerThe immunotherapy option without bevacizumabSystemic treatment with Child-Pugh B liver functionWhen the liver itself is the limiting factor
Talk to us
Told this combination is not safe for you?
Our tumour board can review your endoscopy, scans and blood results and explain the reasoning and the other options. One helpline serves every CION centre.